COVID-19 Research Perspective Volume 12, Issue 8 pp 6492—6510

Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections

class="figure-viewer-img"

Figure 4. The timing of the administration of geroprotectors for prevention, treatment and rehabilitation of gerolavic respiratory diseases.